These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31391566)

  • 41. California stem-cell grants awarded.
    Check Hayden E
    Nature; 2009 Nov; 462(7269):22. PubMed ID: 19890299
    [No Abstract]   [Full Text] [Related]  

  • 42. Stem cells, science, and public reasoning.
    Hurlbut JB; Robert JS
    J Policy Anal Manage; 2012; 31(3):707-14. PubMed ID: 22764379
    [No Abstract]   [Full Text] [Related]  

  • 43. The proceedings of the California Stem Cell Agency.
    Feigal EG; DeWitt ND
    Stem Cells Transl Med; 2014 Jun; 3(6):671-2. PubMed ID: 24771394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The California stem cell initiative: persuasion, politics, and public science.
    Adelson JW; Weinberg JK
    Am J Public Health; 2010 Mar; 100(3):446-51. PubMed ID: 20075315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 46. California: 'the Stem Cell State'. Interview with Jonathan Thomas.
    Thomas J
    Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. State stem cell initiatives. CIRM close-hauled, seeks bonds to sustain headway.
    Holden C
    Science; 2009 Mar; 323(5922):1660-1. PubMed ID: 19325091
    [No Abstract]   [Full Text] [Related]  

  • 48. A new paradigm for funding medical research.
    Klein R
    Stem Cells; 2012 Mar; 30(3):360-2. PubMed ID: 22334458
    [No Abstract]   [Full Text] [Related]  

  • 49. Global update: USA.
    Matthews KR
    Regen Med; 2011 Nov; 6(6 Suppl):136-9. PubMed ID: 21999276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIH stem-cell programme closes.
    Reardon S
    Nature; 2014 Apr; 508(7495):157. PubMed ID: 24717485
    [No Abstract]   [Full Text] [Related]  

  • 51. CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
    Weissman IL; Watt FM
    Cell Stem Cell; 2016 Jul; 19(1):19-22. PubMed ID: 27392224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. California institute woos NIH stem-cell chief.
    Wadman M
    Nature; 2007 Feb; 445(7127):464-5. PubMed ID: 17268434
    [No Abstract]   [Full Text] [Related]  

  • 53. Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea.
    Weinryb N; Bubela T
    Stem Cell Rev Rep; 2016 Feb; 12(1):8-14. PubMed ID: 26432702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The public, political parties, and stem-cell research.
    Blendon RJ; Kim MK; Benson JM
    N Engl J Med; 2011 Nov; 365(20):1853-6. PubMed ID: 22087677
    [No Abstract]   [Full Text] [Related]  

  • 55. California stem cell research unit is admired but needs better governance.
    Roehr B
    BMJ; 2012 Dec; 345():e8398. PubMed ID: 23228969
    [No Abstract]   [Full Text] [Related]  

  • 56. The darker side of stem cells.
    Nature; 2012 Feb; 483(7387):5. PubMed ID: 22382939
    [No Abstract]   [Full Text] [Related]  

  • 57. Collaborations in stem cell science.
    Thomas J
    Regen Med; 2012 Nov; 7(6 Suppl):71-2. PubMed ID: 23210814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The NIH and the regenerative medicine field.
    Rao M
    Regen Med; 2012 Mar; 7(2):129-31. PubMed ID: 22397601
    [No Abstract]   [Full Text] [Related]  

  • 59. Geron's quixotic fate.
    Scott C; Huggett B
    Nat Biotechnol; 2012 Jun; 30(6):497. PubMed ID: 22678383
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.